RecallDepth

Sodium Chloride Inhalation Solution, USP 3%, 60 x 4 mL Sterile Unit-Dose Vials per carton, Rx Only, NDC 0487-9003-60. A vial contains sterile, preservation-free, clear, colorless, aqueous solution as labeled for induction of sputum production where specimen collection is indicated. For respiratory therapy, Solium Chloride Inhalation Solution USP, 3% is used in conjunction with a nebulizer

Company
Nephron Pharmaceuticals Corp.
Recall Initiated
November 16, 2015
Posted
June 27, 2016
Terminated
January 9, 2017
Recall Number
Z-2053-2016
Quantity
11,208 cartons
Firm Location
Orlando, FL

Reason for Recall

Lack of Assurance of Sterility: Internal dye ingress test failure to assure the integrity of the vial.

Distribution

Worldwide Distribution - US including AL, AR, AZ, CA, CO, CT, FL, GA, IL, KY, LA, MA, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, PR, SC, TN, TX, UT, VA, VT, WA, WI, WV and Internationally to Canada.

Lot / Code Info

Lot Number N4745A, Exp 09/16

Root Cause

Process control

Action Taken

Nephron Pharmaceuticals Corporation sent an Urgent Drug Recall letter to all affected customers on November 16, 2015. The letter identified the product, the problem, and the action to be taken by the customer. NPC requested customers remove the affected lots from their inventory, including store shelves. Customers with questions should call 1-844-374-6841

More recalls by Nephron Pharmaceuticals Corp.

View all recalls by this company →